Abstract:Metallothionein (MT) was first identified in 1957 by M. Margosch and B. Vallee as ‘a cadmium protein from equine kidney cortex’. In fact, the small protein was a Cu, Zn-containing protein, with an array of conserved cysteine residues. Since its discovery, intensive study has been focused on this protein, but its functions remain elusive. In 1991, a new small protein, which exhibited neuronal growth-inhibitory activity, was isolated by Y. Ushida et al. from healthy human brain; this protein was subsequently named neuronal growth-inhibitory factor (GIF). It was later found that this protein showed high sequence similarity ( 70%) to MT, together with conserved cysteines and metal content, and it was renamed MT3. The neuronal growth-inhibitory activity of this protein is unique among members of the MT family. In their paper, Ushida et al. wrote that: ‘‘... we do not know the mechanism of growth inhibitory action of GIF, especially why GIF but not MT has growth inhibitory activity, despite [their] homologous sequences.’’ To answer this question we have been carrying out a study of structure–property–reactivity–function relationships. Owing to the conformational flexibility of its polypeptide chain, there is no GIF crystal structure available as yet. The solution structure of the a-domain of rat and human Cd-GIF has been determined by means of NMR spectroscopy, but the structure of the b-domain could not be solved because of insufficient NOE connectivities. However, a model of the b-domain structure of GIF was constructed on the basis of molecular dynamic simulation, and a systematical mutagenesis study has been performed. This has revealed that the particular conformation of TCPCP(5–9) in the b-domain, the exposure of the metal–thiolate clusters, the dynamics of EAAEAE(55–60) in the a-domain and the interdomain interactions are closely connected to the bioactivity of human GIF, as discussed in the first minireview of the series. The two-domain architecture of proteins in the MT family gives rise to their specific properties, such as binding to metals for detoxification of pollutants and homeostasis of essential metals, and a supply of thiols (cysteines) for scavenging free radicals. What then are the differences between GIF and MT1 ⁄ 2 that confer on GIF the specific growth-inhibitory activity? In the second minireview, Faller and colleagues have produced a detailed summary of possible differences in the cluster structure between GIF and MT1 ⁄ 2. The higher dynamics and greater exposure of the metal–thiolate clusters to the outside environment in GIF is thought to result in the high reactivity of this protein. I welcome the controversy introduced in respect of previous studies. In line with Confucian philosophy ‘ (jian ting ze ming)’, contrary results and views can look opposite but sometimes they are complementary, reflecting the same truth from different aspects. Some of the functions of MTs have been uncovered, but the real roles played by GIF are still not clear. In the final minireview, the possible biological functions are discussed by Chung and coworkers. Taking into account the expression and secretion of GIF in brain, and combining studies of neurodegenerative diseases with those of the injured brain, they describe how GIF has neuroprotective functions when administered to the injured brain, as opposed to its neuro-inhibitory actions upon cultured neurons. These authors conclude that ‘the studies to date have only begun to investigate and understand the physiological role of GIF within the brain. Further studies are required to determine the function of GIF within the normal, injured and neurodegenerative brain.’

The Δ33-35 Mutant α-Domain Containing β-Domain-Like M3S9 Cluster Exhibits the Function of α-Domain with M4S11 Cluster in Human Growth Inhibitory Factor

TheΔ33-35 Mutantα-Domain Containingβ-Domain-LikeM3S

Effect of α-domain substitution on the structure, property and function of human neuronal growth inhibitory factor

The Structural and Biological Significance of the EAAEAE Insert in the Α‐domain of Human Neuronal Growth Inhibitory Factor

Important Roles of the Conserved Linker-Kks in Human Neuronal Growth Inhibitory Factor

Functional Di-domain of Neuronal Growth Inhibitory Factor

Study on structure-property-reactivity-function relationship of human neuronal growth inhibitory factor (hGIF).

Neuronal Growth-Inhibitory Factor (Metallothionein-3): Structure-Function Relationships

The Role of Thr5 in Human Neuron Growth Inhibitory Factor

Neuronal Growth‐inhibitory Factor (metallothionein‐3): a Unique Metalloprotein

Growth inhibitory factor (GIF) directly interacts with G-protein Rab3a

Domain Splicing Within Metallothionein Family

Mutation at Glu23 eliminates the neuron growth inhibitory activity of human metallothionein-3.

Preparation of Neuronal Growth Inhibitory Factor Monoclonal Antibody and Studies of Its Epitope

The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein

The Study of Human Growth Inhibitory Factor E58K and E55/58/60Q Mutants

Different protective roles in vitro of α- and β-domains of growth inhibitory factor (GIF) on neuron injuries caused by oxygen free radicals

Molecular Cloning and Identification and Biological Activity of GIF-interacting Protein(s)

The Localization and Colocalization of Neuronal Growth Inhibitory Factor(GIF) and Rab3a in the Brain of the Rat

An Insight of S‐Nitrosylation of Human GIF

Solution Structure and Dynamics of Human Metallothionein-3 (Mt-3)